Publication

Viremia and Clinical Presentation in Nicaraguan Patients Infected With Zika Virus, Chikungunya Virus, and Dengue Virus

Downloadable Content

Persistent URL
Last modified
  • 05/15/2025
Type of Material
Authors
    Jesse Waggoner, Emory UniversityLionel Gresh, Sustainable Sciences InstituteMaria Jose Jose Vargas, Ministry of Health, NicaraguaGabriela Ballesteros, Ministry of Health, NicaraguaYolanda Tellez, Ministry of Health, NicaraguaK. James Soda, Florida State UniversityMalaya K. Sahoo, Stanford UniversityAndrea Nunez, Ministry of Health, NicaraguaAngel Balmaseda, Ministry of Health, NicaraguaEva Harris, University of California BerkeleyBenjamin A. Pinsky, Stanford University
Language
  • English
Date
  • 2016-12-15
Publisher
  • Oxford University Press (OUP): Policy B - Oxford Open Option C
Publication Version
Copyright Statement
  • © The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1058-4838
Volume
  • 63
Issue
  • 12
Start Page
  • 1584
End Page
  • 1590
Grant/Funding Information
  • Studies in Nicaragua were supported by NIH (R01AI099631;; A. B. and U54AI65359; A. B.).
  • This work was supported by National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) (K08AI110528; J. J. W.).
Supplemental Material (URL)
Abstract
  • BACKGROUND:  Zika virus (ZIKV), chikungunya virus (CHIKV), and dengue virus (DENV) cocirculate in Nicaragua. In this study, we sought to compare the quantified viremia and clinical presentation of patients infected with 1 or more of these viruses. METHODS:  Acute-phase serum samples from 346 patients with a suspected arboviral illness were tested using a multiplex real-time reverse-transcription polymerase chain reaction for ZIKV, CHIKV, and DENV. Viremia was quantitated for each detected virus, and clinical information from request forms submitted with each sample was recorded. RESULTS:  A total of 263 patients tested positive for 1 or more viruses: 192 patients tested positive for a single virus (monoinfections) and 71 patients tested positive for 2 or all 3 viruses (coinfections). Quantifiable viremia was lower in ZIKV infections compared with CHIKV or DENV (mean 4.70 vs 6.42 and 5.84 log10 copies/mL serum, respectively; P < .001 for both comparisons), and for each virus, mean viremia was significantly lower in coinfections than in monoinfections. Compared with patients with CHIKV or DENV, ZIKV patients were more likely to have a rash (P < .001) and less likely to be febrile (P < .05) or require hospitalization (P < .001). Among all patients, hospitalized cases had higher viremia than those who did not require hospitalization (7.1 vs 4.1 log10 copies/mL serum, respectively; P < .001). CONCLUSIONS:  ZIKV, CHIKV, and DENV result in similar clinical presentations, and coinfections may be relatively common. Our findings illustrate the need for accurate, multiplex diagnostics for patient care and epidemiologic surveillance.
Author Notes
  • Correspondence: B. A. Pinsky, 3375 Hillview Ave, Rm 2913, Palo Alto, CA 94304, (bpinsky@stanford.edu)
Keywords
Research Categories
  • Biology, Virology
  • Health Sciences, Public Health
  • Health Sciences, Epidemiology

Tools

Relations

In Collection:

Items